Showing results (31-40 of 108) with videos related to
Sort By:
Pageof 11
FEBS Letters|February 16, 2005
Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and EpacSylvain Robert, Marjorie Maillet, Eric Morel, et al.Pharmacological Reports : PR|March 25, 2009
Functional characterization of the cAMP-binding proteins Epac in cardiac myocytesMélanie Métrich, Eric Morel, Magali Berthouze, et al.Circulation Research|March 8, 2008
Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophyMélanie Métrich, Alexandre Lucas, Monique Gastineau, et al.Oncotarget|May 18, 2017
Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activationJaspal Garg, Yu-Xi Feng, Sepp R Jansen, et al.Journal of Computer-Aided Molecular Design|July 24, 2020
Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamicsMarianna Bufano, Marion Laudette, Jean-Paul Blondeau, et al.Pharmacological Research|August 23, 2025
Selective EPAC1 Activators Enhance Endothelial Function in Models of Vascular InflammationNeil MacRitchie, Danila Gurgone, Jolanta Wiejak, et al.Biochemical Pharmacology|August 17, 2005
A high-affinity monoclonal antibody with functional activity against the 5-hydroxytryptaminergic (5-HT4) receptorRehab Kamel, Pierre Eftekhari, Simone Garcia, et al.Pflugers Archiv : European Journal of Physiology|June 30, 2010
Epac stimulation induces rapid increases in connexin43 phosphorylation and function without preconditioning effectNicolas Duquesnes, Mickael Derangeon, Mélanie Métrich, et al.Journal of Molecular and Cellular Cardiology|December 11, 2012
Epac in cardiac calcium signalingGema Ruiz-Hurtado, Eric Morel, Alejandro Domínguez-Rodríguez, et al.The Journal of Biological Chemistry|November 10, 2012
Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein EpacDelphine Courilleau, Malik Bisserier, Jean-Christophe Jullian, et al.Pageof 11